Up-regulation of VEGF by retinoic acid during hyperoxia prevents retinal neovascularization and retinopathy

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 7, 2014, Pages 4276-4286

  Wang, Liya ^a   Shi, Pingling ^a   Xu, Zhongzhong ^a   Li, Jing ^a   Xie, Yanting ^a   Mitton, Kenneth ^b   Drenser, Kimberly ^b   Yan, Qi ^a,b  

^a Henan Eye Institute   (China)

^b OAKLAND UNIVERSITY   (United States)

Author keywords

Hypoxia; IGF 1; OIR; Retinal neovascularization; Retinoic acid; ROP; VEGF

Indexed keywords

HYPOXIA; IGF-1; OIR; RETINAL NEOVASCULARIZATION; RETINOIC ACID; ROP; VEGF;

ANIMALS; ANIMALS, NEWBORN; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HYPEROXIA; IN SITU NICK-END LABELING; MICE; MICE, INBRED C57BL; RETINA; RETINAL NEOVASCULARIZATION; RETINOPATHY OF PREMATURITY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRETINOIN; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84904351731     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.14-14170     Document Type: Article

References (46)

1. Kong L, Fry M, Al-Samarraie M, et al. An update on progress and the changing epidemiology of causes of childhood blindness worldwide. J AAPOS. 2012;16:501-507.
2. Foster A, Gilbert C, Johnson G. Changing patterns in global blindness: 1988-2008. Community Eye Health. 2008;21:37-39.
3. Palmer EA, Patz A, Phelps DL, et al. Retinopathy of prematurity. In: Ryan SJ, ed. Retina. St. Louis, MO: Mosby-Year Book; 2001:1473-1498.
4. Saugstad OD. Oxygen and retinopathy of prematurity. J Perinatol. 2006;26(suppl 1):S46-S50.
5. Gunn DJ, Cartwright DW, Gole GA. Incidence of retinopathy of prematurity in extremely premature infants over an 18-year period. Clin Experiment Ophthalmol. 2012;40:93-99.
6. Blencowe H, Cousens S, Oestergaard MZ, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012;379:2162-2172.
7. Pierce EA, Foley ED, Smith LE. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Ophthalmol. 1996;114:1219-1228.
8. Sonmez K, Drenser KA, Capone A Jr, et al. Vitreous levels of stromal cell-derived factor 1 and vascular endothelial growth factor in patients with retinopathy of prematurity. Ophthalmology. 2008;115:1065-1070. e1.
9. Saito A, Sugawara A, Uruno A, et al. All-trans retinoic acid induces in vitro angiogenesis via retinoic acid receptor: possible involvement of paracrine effects of endogenous vascular endothelial growth factor signaling. Endocrinology. 2007;148:1412-1423.
10. Maeno T, Tanaka T, Sando Y, et al. Stimulation of vascular endothelial growth factor gene transcription by all trans retinoic acid through Sp1 and Sp3 sites in human bronchioloalveolar carcinoma cells. Am J Respir Cell Mol Biol. 2002;26: 246-253.
11. Means AL, Gudas LJ. The roles of retinoids in vertebrate development. Annu Rev Biochem. 1995;64:201-233.
12. De Luca LM. Retinoids and their receptors in differentiation, embryogenesis, and neoplasia. FASEB J. 1991;5:2924-2933.
13. Palczewski K. Retinoids for treatment of retinal diseases. Trends Pharmacol Sci. 2010;31:284-295.
14. Mactier H, Galloway P, Hamilton R, et al. Inadequacy of IV vitamin A supplementation of extremely preterm infants. J Pediatr. 2005;146:846-847.
15. Tyson JE, Wright LL, Oh W, et al. Vitamin A supplementation for extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med. 1999;340:1962-1968.
16. Smith LE, Wesolowski E, McLellan A, et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci. 1994;35: 101-111.
17. James ML, Ross AC, Bulger A, et al. Vitamin A and retinoic acid act synergistically to increase lung retinyl esters during normoxia and reduce hyperoxic lung injury in newborn mice. Pediatr Res. 2010;67:591-597.
18. Massaro GD, Massaro D. Postnatal treatment with retinoic acid increases the number of pulmonary alveoli in rats. Am J Physiol. 1996;270:L305-L310.
19. Connor KM, Krah NM, Dennison RJ, et al. Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat Protoc. 2009;4:1565-1573.
20. Nakamura S, Imai S, Ogishima H, et al. Morphological and functional changes in the retina after chronic oxygen-induced retinopathy. PLoS One. 2012;7:e32167.
21. Saito Y, Geisen P, Uppal A, et al. Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity. Mol Vis. 2007;13:840-853.
22. Zhang SX, Ma JX, Sima J, et al. Genetic difference in susceptibility to the blood-retina barrier breakdown in diabetes and oxygen-induced retinopathy. Am J Pathol. 2005;166:313-321.
23. Koto T, Takubo K, Ishida S, et al. Hypoxia disrupts the barrier function of neural blood vessels through changes in the expression of claudin-5 in endothelial cells. Am J Pathol. 2007; 170:1389-1397.
24. Hellstrom A, Perruzzi C, Ju M, et al. Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci U S A. 2001;98:5804-5808.
25. Alon T, Hemo I, Itin A, et al. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med. 1995;1:1024-1028.
26. De Luca LM. Retinoids and their receptors in differentiation, embryogenesis, and neoplasia. FASEB J. 1991;5:2924-2933.
27. Duester G. Keeping an eye on retinoic acid signaling during eye development. Chem Biol Interact. 2009;178:178-181.
28. Tee MK, Vigne JL, Taylor RN. All-trans retinoic acid inhibits vascular endothelial growth factor expression in a cell model of neutrophil activation. Endocrinology. 2006;147:1264-1270.
29. Kim MS, Kim YK, Eun HC, et al. All-trans retinoic acid antagonizes UV-induced VEGF production and angiogenesis via the inhibition of ERK activation in human skin keratinocytes. J Invest Dermatol. 2006;126:2697-2706.
30. Kini AR, Peterson LA, Tallman MS, et al. Angiogenesis in acute promyelocytic leukemia: induction by vascular endothelial growth factor and inhibition by all-trans retinoic acid. Blood. 2001;97:3919-3924.
31. Weninger W, Rendl M, Mildner M, et al. Retinoids downregulate vascular endothelial growth factor/vascular permeability factor production by normal human keratinocytes. J Invest Dermatol. 1998;111:907-911.
32. Wu J, Hansen JM, Hao L, et al. Retinoic acid stimulation of VEGF secretion from human endometrial stromal cells is mediated by production of reactive oxygen species. J Physiol. 2011;589:863-875.
33. Lundkvist A, Lee S, Iruela-Arispe L, et al. Growth factor gradients in vascular patterning. Novartis Found Symp. 2007; 283:194-201.
34. Stone J, Itin A, Alon T, et al. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci. 1995;15: 4738-4747.
35. Massaro D, Massaro GD. Retinoids, alveolus formation, and alveolar deficiency: clinical implications. Am J Respir Cell Mol Biol. 2003;28:271-274.
36. Biesalski HK. The significance of vitamin A for the development and function of the lung. Forum Nutr. 2003;56:37-40.
37. Veness-Meehan KA, Pierce RA, Moats-Staats BM, et al. Retinoic acid attenuates O2-induced inhibition of lung septation. Am J Physiol Lung Cell Mol Physiol. 2002;283:L971-980.
38. Degos L, Wang ZY. All trans retinoic acid in acute promyelocytic leukemia. Oncogene. 2001;20:7140-7145.
39. Tielsch JM, Rahmathullah L, Thulasiraj RD, et al. Newborn vitamin A dosing reduces the case fatality but not incidence of common childhood morbidities in South India. J Nutr. 2007; 137:2470-2474.
40. Lee LM, Leung CY, Tang WW, et al. A paradoxical teratogenic mechanism for retinoic acid. Proc Natl Acad Sci U S A. 2012; 109:13668-13673.
41. Quemelo PR, Lourenço CM, Peres LC. Teratogenic effect of retinoic acid in swiss mice. Acta Cir Bras. 2007;22:451-456.
42. Akiyama H, Tanaka T, Maeno T, et al. Induction of VEGF gene expression by retinoic acid through Sp1-binding sites in retinoblastoma Y79 cells. Invest Ophthalmol Vis Sci. 2002; 43:1367-1374.
43. Stalmans I, Ng YS, Rohan R, et al. Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J Clin Invest. 2002;109:327-336.
44. Langford K, Nicolaides K, Miell JP. Maternal and fetal insulinlike growth factors and their binding proteins in the second and third trimesters of human pregnancy. Hum Reprod. 1998; 13:1389-1393.
45. Smith LE. IGF-1 and retinopathy of prematurity in the preterm infant. Biol Neonate. 2005;88:237-244.
46. Darlow BA, Graham PJ. Vitamin A supplementation to prevent mortality and short and long-term morbidity in very low birthweight infants. Cochrane Database Syst Rev. 2007;4:doi: 10.1001/14651858.